NSRX
$2.67+0.19 (+7.66%)
Market ClosedAs of Mar 20, 8:00 PM UTC
Nasus Pharma Ltd.
Historical Price
Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$2.67
Potential Upside
5%
Whystock Fair Value$2.80
Price
UndervaluedFair ValueOvervalued
Fundamentals
Nasus Pharma Ltd. operates as a clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions. The company offers Powder-Based Intranasal (PBI) products to address acute medical c...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$31.27M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Elite ROE. Management converts capital into profit efficiently.
47.70%
Quick Ratio
Tight liquidity. Monitor cash flow carefully against debt.
0.12
Recent News
No recent news found.